The Verisyse™ Phakic IOL is used to treat moderate to severe myopia, the medical term for near-sightedness. With over 18 years of use and 150,000 procedures performed worldwide, results prove that the Verisyse™ design is safe and effective for highly near-sighted people who are tired of thick glasses and are not candidates for LASIK eye surgery. Kenneth P. Kato, M.D. is one of only 300 refractive surgeons in the United States who has been trained to treat patients with the Verisyse™ phakic intraocular lens (IOL).

The procedure involves placing the Verisyse™ Phakic IOL behind your cornea and on top of your iris. This gives your eye another focusing lens that provides high-quality, high-definition vision like a normal eye. Although the Verisyse™ Phakic IOL is intended to be permanent, the procedure is reversible if desired. The word "phakic" means that your natural crystalline lens is left in the eye. This is important because your natural lens plays an important role in helping your eye adjust between seeing objects that are near and far. Implanting the Verisyse™ Phakic IOL is an outpatient procedure that takes around 15 to 30 minutes.

While the Verisyse™ lens has been approved in the United States for only a short time, it is estimated that more than 150,000 procedures have been conducted worldwide over the past 15 years with excellent results and a remarkable safety profile.

For more information, please visit www.visioninfocus.com.